# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-22-072614
Filing Date
2022-06-21
Accepted
2022-06-21 06:19:40
Documents
93
Period of Report
2022-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2218885d1_8k.htm iXBRL | 8-K | 27473
2 | EXHIBIT 99.1 | tm2218885d1_ex99-1.htm | EX-99.1 | 89823
6 | GRAPHIC | tm2218885d1_ex99-1img01.jpg | GRAPHIC | 558073
7 | GRAPHIC | tm2218885d1_ex99-1img02.jpg | GRAPHIC | 824171
8 | GRAPHIC | tm2218885d1_ex99-1img03.jpg | GRAPHIC | 644510
9 | GRAPHIC | tm2218885d1_ex99-1img04.jpg | GRAPHIC | 425959
10 | GRAPHIC | tm2218885d1_ex99-1img05.jpg | GRAPHIC | 333593
11 | GRAPHIC | tm2218885d1_ex99-1img06.jpg | GRAPHIC | 568995
12 | GRAPHIC | tm2218885d1_ex99-1img07.jpg | GRAPHIC | 555417
13 | GRAPHIC | tm2218885d1_ex99-1img08.jpg | GRAPHIC | 289832
14 | GRAPHIC | tm2218885d1_ex99-1img09.jpg | GRAPHIC | 333291
15 | GRAPHIC | tm2218885d1_ex99-1img10.jpg | GRAPHIC | 500528
16 | GRAPHIC | tm2218885d1_ex99-1img11.jpg | GRAPHIC | 238744
17 | GRAPHIC | tm2218885d1_ex99-1img12.jpg | GRAPHIC | 489676
18 | GRAPHIC | tm2218885d1_ex99-1img13.jpg | GRAPHIC | 490988
19 | GRAPHIC | tm2218885d1_ex99-1img14.jpg | GRAPHIC | 459192
20 | GRAPHIC | tm2218885d1_ex99-1img15.jpg | GRAPHIC | 396484
21 | GRAPHIC | tm2218885d1_ex99-1img16.jpg | GRAPHIC | 544291
22 | GRAPHIC | tm2218885d1_ex99-1img17.jpg | GRAPHIC | 398067
23 | GRAPHIC | tm2218885d1_ex99-1img18.jpg | GRAPHIC | 448866
24 | GRAPHIC | tm2218885d1_ex99-1img19.jpg | GRAPHIC | 463817
25 | GRAPHIC | tm2218885d1_ex99-1img20.jpg | GRAPHIC | 512333
26 | GRAPHIC | tm2218885d1_ex99-1img21.jpg | GRAPHIC | 382997
27 | GRAPHIC | tm2218885d1_ex99-1img22.jpg | GRAPHIC | 503406
28 | GRAPHIC | tm2218885d1_ex99-1img23.jpg | GRAPHIC | 444690
29 | GRAPHIC | tm2218885d1_ex99-1img24.jpg | GRAPHIC | 482187
30 | GRAPHIC | tm2218885d1_ex99-1img25.jpg | GRAPHIC | 454011
31 | GRAPHIC | tm2218885d1_ex99-1img26.jpg | GRAPHIC | 435278
32 | GRAPHIC | tm2218885d1_ex99-1img27.jpg | GRAPHIC | 368855
33 | GRAPHIC | tm2218885d1_ex99-1img28.jpg | GRAPHIC | 372007
34 | GRAPHIC | tm2218885d1_ex99-1img29.jpg | GRAPHIC | 236917
35 | GRAPHIC | tm2218885d1_ex99-1img30.jpg | GRAPHIC | 244593
36 | GRAPHIC | tm2218885d1_ex99-1img31.jpg | GRAPHIC | 489335
37 | GRAPHIC | tm2218885d1_ex99-1img32.jpg | GRAPHIC | 358386
38 | GRAPHIC | tm2218885d1_ex99-1img33.jpg | GRAPHIC | 304733
39 | GRAPHIC | tm2218885d1_ex99-1img34.jpg | GRAPHIC | 307588
40 | GRAPHIC | tm2218885d1_ex99-1img35.jpg | GRAPHIC | 524948
41 | GRAPHIC | tm2218885d1_ex99-1img36.jpg | GRAPHIC | 446849
42 | GRAPHIC | tm2218885d1_ex99-1img37.jpg | GRAPHIC | 373002
43 | GRAPHIC | tm2218885d1_ex99-1img38.jpg | GRAPHIC | 342729
44 | GRAPHIC | tm2218885d1_ex99-1img39.jpg | GRAPHIC | 471931
45 | GRAPHIC | tm2218885d1_ex99-1img40.jpg | GRAPHIC | 334571
46 | GRAPHIC | tm2218885d1_ex99-1img41.jpg | GRAPHIC | 433905
47 | GRAPHIC | tm2218885d1_ex99-1img42.jpg | GRAPHIC | 431827
48 | GRAPHIC | tm2218885d1_ex99-1img43.jpg | GRAPHIC | 419464
49 | GRAPHIC | tm2218885d1_ex99-1img44.jpg | GRAPHIC | 444472
50 | GRAPHIC | tm2218885d1_ex99-1img45.jpg | GRAPHIC | 239116
51 | GRAPHIC | tm2218885d1_ex99-1img46.jpg | GRAPHIC | 461373
52 | GRAPHIC | tm2218885d1_ex99-1img47.jpg | GRAPHIC | 410889
53 | GRAPHIC | tm2218885d1_ex99-1img48.jpg | GRAPHIC | 539773
54 | GRAPHIC | tm2218885d1_ex99-1img49.jpg | GRAPHIC | 445554
55 | GRAPHIC | tm2218885d1_ex99-1img50.jpg | GRAPHIC | 374784
56 | GRAPHIC | tm2218885d1_ex99-1img51.jpg | GRAPHIC | 438531
57 | GRAPHIC | tm2218885d1_ex99-1img52.jpg | GRAPHIC | 427980
58 | GRAPHIC | tm2218885d1_ex99-1img53.jpg | GRAPHIC | 515389
59 | GRAPHIC | tm2218885d1_ex99-1img54.jpg | GRAPHIC | 494762
60 | GRAPHIC | tm2218885d1_ex99-1img55.jpg | GRAPHIC | 492782
61 | GRAPHIC | tm2218885d1_ex99-1img56.jpg | GRAPHIC | 471251
62 | GRAPHIC | tm2218885d1_ex99-1img57.jpg | GRAPHIC | 417397
63 | GRAPHIC | tm2218885d1_ex99-1img58.jpg | GRAPHIC | 399084
64 | GRAPHIC | tm2218885d1_ex99-1img59.jpg | GRAPHIC | 400953
65 | GRAPHIC | tm2218885d1_ex99-1img60.jpg | GRAPHIC | 469975
66 | GRAPHIC | tm2218885d1_ex99-1img61.jpg | GRAPHIC | 433454
67 | GRAPHIC | tm2218885d1_ex99-1img62.jpg | GRAPHIC | 315911
68 | GRAPHIC | tm2218885d1_ex99-1img63.jpg | GRAPHIC | 336776
69 | GRAPHIC | tm2218885d1_ex99-1img64.jpg | GRAPHIC | 428104
70 | GRAPHIC | tm2218885d1_ex99-1img65.jpg | GRAPHIC | 339041
71 | GRAPHIC | tm2218885d1_ex99-1img66.jpg | GRAPHIC | 406189
72 | GRAPHIC | tm2218885d1_ex99-1img67.jpg | GRAPHIC | 362808
73 | GRAPHIC | tm2218885d1_ex99-1img68.jpg | GRAPHIC | 330792
74 | GRAPHIC | tm2218885d1_ex99-1img69.jpg | GRAPHIC | 320323
75 | GRAPHIC | tm2218885d1_ex99-1img70.jpg | GRAPHIC | 343708
76 | GRAPHIC | tm2218885d1_ex99-1img71.jpg | GRAPHIC | 306149
77 | GRAPHIC | tm2218885d1_ex99-1img72.jpg | GRAPHIC | 283961
78 | GRAPHIC | tm2218885d1_ex99-1img73.jpg | GRAPHIC | 358146
79 | GRAPHIC | tm2218885d1_ex99-1img74.jpg | GRAPHIC | 421166
80 | GRAPHIC | tm2218885d1_ex99-1img75.jpg | GRAPHIC | 482714
81 | GRAPHIC | tm2218885d1_ex99-1img76.jpg | GRAPHIC | 590338
82 | GRAPHIC | tm2218885d1_ex99-1img77.jpg | GRAPHIC | 554284
83 | GRAPHIC | tm2218885d1_ex99-1img78.jpg | GRAPHIC | 619265
84 | GRAPHIC | tm2218885d1_ex99-1img79.jpg | GRAPHIC | 560286
85 | GRAPHIC | tm2218885d1_ex99-1img80.jpg | GRAPHIC | 492185
| Complete submission text file | 0001104659-22-072614.txt |  | 47673476

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | lgnd-20220621.xsd | EX-101.SCH | 3027
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lgnd-20220621_lab.xml | EX-101.LAB | 34476
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lgnd-20220621_pre.xml | EX-101.PRE | 22591
87 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2218885d1_8k_htm.xml | XML | 3618

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 221025924
SIC: 2834 Pharmaceutical Preparations